Effect of Valsartan With Bedtime Dosing on Chronic Kidney Disease Patients With Nondipping Blood Pressure Pattern
Authors:
- 9 October 2012
- journal article
- research article
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 15 (1) , 48-54
Abstract
Nondipping blood pressure (BP) pattern is a potential independent risk factor for chronic kidney disease (CKD). Bedtime administration of valsartan is considered to normalize circadian rhythm and protect the kidneys and heart in CKD patients. However, more clinical trials are needed to confirm this benefit. Sixty patients with nondipping BP pattern and thirty patients with dipping BP pattern were enrolled in this study, and the patients with nondipping BP pattern were randomly divided into two groups and treated with bedtime or awakening doses of valsartan (80–320 mg). Nondipping BP patients treated with bedtime doses of valsartan showed a greater reduction in 24‐hour proteinuria and bedtime proteinuria, a greater delayed decline in estimated glomerular filtration rate, and more protection against myocardial hypertrophy (P<.05) compared with patients with the nondipping BP pattern treated with the awakening dose (P<.05). This was similar to patients with dipping BP. No severe clinical complications were recorded in these patients. Valsartan with bedtime dosing in CKD patients with the nondipping BP pattern have better renal and cardiovascular protection. Antihypertensive “chronotherapy” may be useful in clinical practice for CKD patients.Keywords
This publication has 17 references indexed in Scilit:
- Bedtime Dosing of Antihypertensive Medications Reduces Cardiovascular Risk in CKDJournal of the American Society of Nephrology, 2011
- Chronotherapy With Valsartan/Hydrochlorothiazide Combination in Essential Hypertension: Improved Sleep-Time Blood Pressure Control With Bedtime DosingChronobiology International, 2011
- CHRONOTHERAPY WITH VALSARTAN/AMLODIPINE FIXED COMBINATION: IMPROVED BLOOD PRESSURE CONTROL OF ESSENTIAL HYPERTENSION WITH BEDTIME DOSINGChronobiology International, 2010
- Reduction of morning blood pressure surge after treatment with nifedipine GITS at bedtime, but not upon awakening, in essential hypertensionBlood Pressure Monitoring, 2009
- Disparate Estimates of Hypertension Control From Ambulatory and Clinic Blood Pressure Measurements in Hypertensive Kidney DiseaseHypertension, 2009
- Administration‐Time‐Dependent Effects of Olmesartan on the Ambulatory Blood Pressure of Essential Hypertension PatientsChronobiology International, 2009
- 2007 Guidelines for the Management of Arterial HypertensionJournal Of Hypertension, 2007
- Importance of Blood Pressure Control in Chronic Kidney DiseaseJournal of the American Society of Nephrology, 2006
- Decrease in Urinary Albumin Excretion Associated With the Normalization of Nocturnal Blood Pressure in Hypertensive SubjectsHypertension, 2005
- Administration Time–Dependent Effects of Valsartan on Ambulatory Blood Pressure in Hypertensive SubjectsHypertension, 2003